Markets

Insider Trading

Hedge Funds

Retirement

Opinion

15 Best U.S. Stocks to Buy Now Under $10

In this article, we will discuss the 15 best U.S. stocks to buy now under $10. If you want to explore similar stocks, you can also take a look at 5 Best U.S. Stocks to Buy Now Under $10.

The U.S. has always been a financial and economic hub, home to some of the biggest companies in various sectors. In the list of the 100 most valuable companies in the world, 61 companies are from the U.S. The dominance is further affirmed by the fact that the country accounts for nine of the top ten most valuable companies.

U.S. companies have always dominated technological innovations, going by the billions of dollars spent on research and development over the years. Spending on R&D increased by $51 billion in 2021 to $791 billion, affirming America’s leading status on spending on innovation and groundbreaking solutions.

The culture of innovation and entrepreneurship is also robust and has given rise to startups that have gone on to become multi-billion empires. OpenAI is one such startup that is spearheading the artificial intelligence race, attracting billions of dollars in investments.

Apple Inc. (NASDAQ:AAPL), the most valuable company in the world with a market cap of about $2.7 trillion, has affirmed the U.S. dominance in the development of smartphones, laptops and other solutions. Amazon is another company that affirms U.S. dominance in commerce as Microsoft Corporation (NASDAQ:MSFT) continues to call the shots on software development.

Alphabet Inc. (NASDAQ:GOOG) runs a monopoly on internet search and advertising while Meta Platforms dominate social networking, and NVIDIA Corporation (NASDAQ:NVDA) spearheads the artificial intelligence revolution with some of the most powerful chips.

Source:unsplash

The U.S. Federal Reserve’s refraining from hiking interest rates at its September meeting might have boosted the investment landscape for small-cap stocks.

The pause was much needed as it averts the risk of the U.S. economy plunging into recession. With the prospect of the Fed cutting interest rates next year, sentiments in the equity markets are on an upward trajectory. Stocks trading below $10 a share remain well positioned to benefit from the Fed going slow on interest rate hikes. Interest rate cuts should lower borrowing costs, making it easy for these companies to access cheap capital through loans and other investments to finance their growth plans. For long-term investors, now could be the best time to take a closer look at stocks trading at highly discounted levels, especially those trading below $10 a share, as underlying fundamentals improve.

Our Methodology

We looked at the stock holdings of 910 hedge funds in our database and selected 15 US stocks trading under $10 with the highest number of hedge fund investors. That way, these are the best US stocks to buy now under $10 according to smart money investors.

15. Compass, Inc. (NYSE:COMP)

Share Price as of September 22: $3.37

Number of Hedge Fund Holders: 26

Compass, Inc. (NYSE:COMP) is a company from the U.S. that offers software and technology solutions for the travel industry worldwide. It operates the largest global distribution system for air bookings in North America. As of September 22, 2023, the stock price of Compass, Inc. (NYSE:COMP) was $3.37 per share, which was a 1.26% increase from the previous close of $3.18 per share. The stock had a 52-week range of $1.84 to $5.16 per share.

By the end of this year’s second quarter, 26 hedge funds out of the 910 tracked by Insider Monkey had bought the firm’s shares. Compass, Inc. (NYSE:COMP)’s largest hedge fund investor among these is Richard Mashaal’s Rima Senvest Management through its $52.44 million stake.

Compass, Inc. (NYSE:COMP) has a ‘Moderate Buy’ rating from 4 buys, 4 holds and 0 sells. The average target price is $4.53, ranging from $3.50 to $6.00.

14. Altice USA, Inc. (NYSE:ATUS

Share Price as of September 21: $3.38

Number of Hedge Fund Holders: 26

Altice USA, Inc. (NYSE:ATUS), a company that provides broadband communications and video services, has a ‘Hold’ rating from nine analysts who follow the stock.

During Q2 2023, 26 out of the 910 hedge funds part of Insider Monkey’s database had held a stake in Altice USA, Inc. (NYSE:ATUS). Out of these, the firm’s biggest investor is Cliff Asness’ AQR Capital Management since it owns 17.14 million shares that are worth $50.40 million.

13. Applied Digital Corporation (NASDAQ:APLD

Share Price as of September 22: $5.20

Number of Hedge Fund Holders: 26

Applied Digital Corporation (NASDAQ:APLD) is a digital infrastructure provider with a ‘Strong Buy’ rating from 6 buys and 0 holds or sells.

According to Insider Monkey’s second-quarter database, 26 hedge funds were bullish on Applied Digital Corporation (NASDAQ:APLD), compared to 11 funds in the preceding quarter.

12. T.G. Therapeutics, Inc. (NASDAQ:TGTX

Share Price as of September 22: $9.25

Number of Hedge Fund Holders: 26

T.G. Therapeutics, Inc. (NASDAQ:TGTX) is a company that creates and sells new therapies for diseases of B-cells, such as cancers and autoimmune conditions. It has two approved products: BRIUMVI, a monoclonal antibody for relapsing forms of multiple sclerosis, and UKONIQ, a kinase inhibitor for certain types of lymphoma and leukemia. It also has several other drug candidates in clinical trials or preclinical development.

Insider Monkey surveyed 910 hedge funds to look at their Q2 2023 portfolios and found out that 26 had held T.G. Therapeutics, Inc. (NASDAQ:TGTX)’s shares. T.G. Therapeutics, Inc. (NASDAQ:TGTX)’s largest hedge fund investor in our database is Abhishek Trehan’s Darwin Global Management with a $230.48 million stake.

13. Brookdale Senior Living Inc. (NYSE:BKD

Share Price as of September 22: $4.30

Number of Hedge Fund Holders: 27

Brookdale Senior Living Inc. (NYSE:BKD) is a company that provides senior living services in the U.S. It has three segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRCs).

The company has a ‘Hold’ rating from three analysts, with one buy, one hold, and one sell. The average price target is $5.98, which means a 38.11% increase from the current price of $4.30 as of September 22, 2023. The price target range is $3.95 to $7.

According to Insider Monkey’s second-quarter database, 27 hedge funds were bullish on Brookdale Senior Living Inc. (NYSE:BKD), compared to 30 funds in the prior quarter.

12. Yext, Inc. (NYSE:YEXT

Share Price as of September 22: $6.17

Number of Hedge Fund Holders: 27

Yext, Inc. (NYSE:YEXT) is a company that helps businesses provide accurate and consistent answers to consumers’ queries across various platforms and devices. It operates in North America and other countries around the world.

Yext Inc. is rated ‘Hold’ by analysts, with no buys or sells and 3 holds. Its stock price could go up from $6.17 to $11, a 78.28% increase.

According to Insider Monkey’s second-quarter database, 27 hedge funds were long Yext, Inc. (NYSE:YEXT), compared to 28 funds in the prior quarter. Mitchell Green’s Lead Edge Capital is the largest stakeholder of the company, with 11.47 million shares worth $129.77 million.

9. Harmonic Inc. (NASDAQ:HLIT

Share Price as of September 22: $9.57

Number of Hedge Fund Holders: 27

Harmonic Inc. (NASDAQ:HLIT) is a company that specializes in video delivery solutions for various applications, such as broadcast, cable, satellite, internet, and mobile. On August 10, Raymond James analyst Simon Leopold upgraded Harmonic Inc. (NASDAQ:HLIT) from ‘Outperform’ to ‘Strong Buy’ and boosted the price target from $15 to $16.

At the end of Q2 2023, 27 hedge funds were long Harmonic Inc. (NASDAQ:HLIT). This is compared to 25 hedge funds in the previous quarter. As of June 30, Trigran Investments is the top stockholder in the company and has a position worth $112.53 million.

8. Acelyrin, Inc. (NASDAQ:SLRN)

Share Price as of September 22: $9.95

Number of Hedge Fund Holders: 27

Acelyrin, Inc. (NASDAQ:SLRN) is a biopharmaceutical company from the U.S. that creates and sells innovative medicines for various diseases. Its lead drug candidate is izokibep, a monoclonal antibody for the treatment of hidradenitis suppurativa, a chronic inflammatory skin condition. As of June 2023, 27 out of the 910 hedge funds surveyed by Insider Monkey were the firm’s investors.

Morgan Stanley’s Vikram Purohit lowered Acelyrin, Inc. (NASDAQ:SLRN) from ‘Overweight’ to ‘Equalweight’ and cut its price target from $39 to $19 on September 13. He said the company failed to meet the main goal of its trial due to high dropout rate and strong placebo effect. He said he was uncertain about the company’s prospects and would re-evaluate later in 2023.

7. Sabre Corporation (NASDAQ:SABR

Share Price as of September 22: $4.48

Number of Hedge Fund Holders: 28

Sabre Corporation (NASDAQ:SABR) is a travel software and technology company. It has a ‘Hold’ rating from four analysts, with no buy and one sell. The average price target is $4.63, which is a 3.35% increase from the current price of $4.48 as of September 22, 2023. The price target range is $4 to $5.50.

It is one of the best U.S. stocks under $10 to invest in now. It makes the cut at seventh on our list of 15 top stocks.

28 out of the 910 hedge funds part of Insider Monkey’s Q2 2023 database had bought Sabre Corporation (NASDAQ:SABR)’s shares. Terry Smith’s Fundsmith LLP is the biggest investor among these due to its $72.44 million stake.

6. Sutro Biopharma, Inc. (NASDAQ:STRO

Share Price as of September 21: $3.55

Number of Hedge Fund Holders: 28

Sutro Biopharma, Inc. (NASDAQ:STRO), a company that develops novel therapies for cancer and autoimmune diseases, has a ‘Strong Buy’ rating from five analysts who cover the stock. None of the analysts have a hold or sell rating on the stock. The average price target for Sutro Biopharma Inc. is $17.60.

According to Insider Monkey’s second-quarter database, 28 hedge funds were bullish on Sutro Biopharma, Inc. (NASDAQ:STRO), up from 22 in the prior quarter. Aaron Cowen’s Suvretta Capital Management is the leading stakeholder of the company, with 5.88 million shares worth $27.36 million.

Click to continue reading and see 5 Best U.S. Stocks to Buy Now Under $10.

Suggested articles:

Disclosure: None. 15 Best U.S. Stocks to Buy Now Under $10 is originally published on Insider Monkey.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

If you’re thinking about getting in, don’t wait – because once Wall Street catches wind of this story, the easy money will be gone.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99 a month.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!